BioSpace News Archive

Petros Pharmaceuticals, Inc. announces today that President and Chief Commercial Officer Fady Boctor will present at the H.C. Wainwright Global Investment Conference, which is being held virtually from September 13 – 15, 2021.

Gemini Therapeutics, Inc. today announced one oral presentation and the presentation of three posters at the 13th International Conference on Complement Therapeutics held in Ioannina, Greece from September 8-13, 2021.

Applied UV, Inc. (NASDAQ:AUVI) (“Applied UV” or the “Company”), announced that Q Saeed, CEO of Applied UV, will present at the virtual H.C. Wainwright Global Investor Conference.

WithHealth, Inc. (the “Company”), a precision concierge care telehealth company for employers and their employees, is ready to assist employers as they work to meet the new vaccine and testing requirements announced by the Biden administration.

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today the engagement of Venvalo Group to assist the Company on regulatory, strategic, and implementation aspects of the recently FDA-cleared Phase III clinical trial assessing ability of JadiCells to treat patients with advanced COVID-19.

Synaptogenix, Inc (Nasdaq: SNPX), an emerging biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, today announced it will be featured as a presenting company at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference.

Lennham’s new patent family is based on newly discovered metabolic properties of psilocybin

Mirum Pharmaceuticals, Inc. announced that on September 10, 2021, the Compensation Committee of Mirum’s Board of Directors granted non-qualified stock option awards to purchase an aggregate of 87,500 shares of common stock to ten new employees under Mirum’s 2020 Inducement Plan.

The cell & gene therapy manufacturing services market is majorly driven by rising agreements and partnerships between CDMOs and pharmaceutical companies.

According to the report, the global laparoscopy devices market was valued at US$ 8.5 Bn in 2019 and is projected to expand at a CAGR of 6.5% from 2020 to 2030.